Overview

Safety and Efficacy Study to Evaluate Proellex in the Treatment of Premenopausal Women With Symptomatic Endometriosis

Status:
Terminated

Trial end date:
2009-07-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether Proellex is safe and effective for the treatment of symptomatic endometriosis.

Phase:

Phase 2

Details

Lead Sponsor:

Repros Therapeutics Inc.